To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
August 15, 2006
John L. Rinn, PhD (Damon Runyon Fellow '05-'08) and Howard Y. Chang, MD, PhD (Kenneth G. and Elaine A. Langone Damon Runyon Scholar '06-'08) were featured in Newsday and the New York Times for their discovery of a kind of "blue print" system that defines each cell's position in the body. Future studies with this coordinate system may contribute to our understanding of the wound healing process and may be useful in generating human tissues. Ultimately, these "blue prints" could have a profound impact on how cancer cells are tracked, identifying the spread of tumor cells earlier and more efficiently.